Related Experiment Video
Updated: Jul 19, 2026

13:14
Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
Published on: February 6, 2018
A molecular immunology approach to antibody humanization and functional optimization
Greg A Lazar1, John R Desjarlais, Jonathan Jacinto
1Xencor, 111 W. Lemon Avenue, Monrovia, CA 91016, USA.
Molecular Immunology
|November 3, 2006
Summary
This study introduces a new antibody humanization method using human string content (HSC) to improve immunogenicity and antigen binding. The approach generates diverse, more human antibody candidates by optimizing at a finer sequence resolution.
Area of Science:
- Immunology
- Biotechnology
- Computational Biology
Background:
- Antibody humanization is crucial for reducing immunogenicity in therapeutic antibodies.
- Current methods like CDR grafting have limitations in achieving optimal humanness and retaining binding affinity.
Purpose of the Study:
- To introduce a novel antibody humanization method based on human string content (HSC).
- To demonstrate improved immunogenicity and antigen binding compared to traditional methods.
Main Methods:
- Developed a new metric, human string content (HSC), to quantify antibody humanness at the epitope level.
- Utilized HSC as an optimization goal to sample diverse human germline sequences.
- Applied the method to humanize four antibodies with varying specificities.
Main Results:
- Generated antibody variable domains that are immunologically more human than those from CDR grafting.
- Achieved superior or comparable antigen binding affinity without affinity maturation.
- Demonstrated that humanness is derived from multiple discrete germline sequences.
Conclusions:
- The HSC-based humanization method offers a more refined approach to antibody engineering.
- This method enhances antibody properties beyond immunogenicity, including antigen affinity and stability.
- The approach allows for the generation of multiple, diverse, and highly humanized antibody candidates.
Related Concept Videos
Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Antibody Structure
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibody Structure
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibody Structure and Classes
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
Humoral Immune Responses
Overview

